Allergan EPS beats by $0.69, beats on revenu

Allergan (NYSE:AGN): Q4 Non-GAAP EPS of $5.22 beats by $0.69; GAAP EPS of -$0.97 misses by $1.48.

Revenue of $4.35B (+6.6% Y/Y) beats by $260M.

Shares +0.74% PM.

Press Release

https://seekingalpha.com/news/3539947-allergan-eps-beats-0_69-beats-on-revenue